Comments
Loading...
Rapport Therapeutics Stock Price, Quotes and Forecasts
RAPPNASDAQ
Rapport Therapeutics (RAPP) Forecast
NewsEarningsRapport Therapeutics (RAPP) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Rapport Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:RAPP | Benzinga
Explore Rapport Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RAPP.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Rapport Therapeutics (RAPP) stock?
You can purchase shares of Rapport Therapeutics (NASDAQ:RAPP) through any online brokerage.
Who are Rapport Therapeutics (RAPP) competitors?
Other companies in Rapport Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH) and GH Research (NASDAQ:GHRS).
What is the forecast, or price target, for Rapport Therapeutics (RAPP) stock?
Rapport Therapeutics has a consensus price target of $35.00.
What is the current price for Rapport Therapeutics (RAPP)?
The stock price for Rapport Therapeutics (NASDAQ: RAPP) is $11.095 last updated May 8, 2025 at 1:10 PM EDT.
Does Rapport Therapeutics (RAPP) pay a dividend?
There are no upcoming dividends for Rapport Therapeutics.
When is Rapport Therapeutics (NASDAQ:RAPP) reporting earnings?
Rapport Therapeutics’s Q2 earnings are confirmed for Thursday, August 7, 2025.
Is Rapport Therapeutics (RAPP) going to split?
There is no upcoming split for Rapport Therapeutics.
What sector and industry does Rapport Therapeutics (RAPP) operate in?
Rapport Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
